drugset / Trial / NCT02794740
Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
Primary Objectives: To evaluate the safety and tolerability of escalating single and multiple doses of X0002 administered as a topical application. Secondary Objectives: To characterize the single and and multiple pharmacokinetics of escalating doses of X0002 and its active metabolite ibuprofen as a topical application.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-03
- Completion
- 2017-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBUPROFEN TRELAMINE | Small molecule | — | Topical |